Deutsche Bank Aktiengesellschaft Reiterates “Buy” Rating for Advanced Medical Solutions Group (LON:AMS)

Advanced Medical Solutions Group (LON:AMS)‘s stock had its “buy” rating reissued by Deutsche Bank Aktiengesellschaft in a research report issued to clients and investors on Wednesday, Marketbeat.com reports. They presently have a GBX 275 ($3.69) price target on the stock. Deutsche Bank Aktiengesellschaft’s price objective would indicate a potential upside of 32.85% from the stock’s current price.

Separately, Berenberg Bank reiterated a “buy” rating and issued a GBX 300 ($4.03) target price on shares of Advanced Medical Solutions Group in a report on Tuesday.

Advanced Medical Solutions Group Stock Performance

Shares of Advanced Medical Solutions Group stock opened at GBX 207 ($2.78) on Wednesday. The company has a market capitalization of £446.97 million, a PE ratio of 40.11, a P/E/G ratio of 5.00 and a beta of 0.74. The company has a debt-to-equity ratio of 37.01, a quick ratio of 4.58 and a current ratio of 8.39. The company has a 50-day simple moving average of GBX 204.59 and a two-hundred day simple moving average of GBX 204.52. Advanced Medical Solutions Group has a one year low of GBX 168.40 ($2.26) and a one year high of GBX 275.83 ($3.70).

Insider Buying and Selling

In other Advanced Medical Solutions Group news, insider A Christopher (Chris) Meredith sold 64,000 shares of the company’s stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of GBX 195 ($2.62), for a total value of £124,800 ($167,584.26). Also, insider Eddie Johnson sold 16,402 shares of the company’s stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of GBX 195 ($2.62), for a total value of £31,983.90 ($42,948.70). In the last quarter, insiders sold 435,255 shares of company stock worth $84,691,330. 3.12% of the stock is owned by insiders.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.